Government and Regulatory Policy
CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.
Overview
CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.
Key developments include trump administration moves to end animal testing requirements for drug safety research, supreme court rejects challenge to medicare drug price negotiation, lawsuit challenges trump administration rule threatening federal funding for pennsylvania reproductive health providers serving 160,000 patients, among other significant events and policy changes.